Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

S-1

SEC Filing Details

Document Details

Form
Filing Date
Apr 2, 2012
Document Date
Apr 2, 2012
Form Description
Registration statement for face-amount certificate companies
Filing Group
Registration Statements
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved